cisapride has been researched along with Chronic Disease in 49 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of cisapride (10 mg three times daily) on the stool evacuation characteristics, laxative consumption (symptom diary) and motility pattern (rectoanal manometry) were assessed in patients with chronic idiopathic constipation who fulfilled Rome II criteria." | 9.10 | The efficacy of cisapride vs. placebo and diet in patients with chronic constipation. ( Altabas, K; Bilić, A; Dorosulić, Z; Jurcić, D; Mihanović, M; Restek-Petrović, B; Sunić-Omejc, M; Tolj, N, 2003) |
| "To determine whether cisapride is effective in the treatment of children with constipation." | 9.09 | Cisapride for the treatment of constipation in children: A double-blind study. ( Garcia-Aranda, JA; Nurko, S; Worona, LB; Zlochisty, O, 2000) |
| "Cisapride may have a role in the management of chronic idiopathic constipation in children." | 9.09 | Cisapride in management of chronic pediatric constipation. ( Halabi, IM, 1999) |
| "This study confirmed the efficacy of cisapride in chronic idiopathic constipation." | 9.08 | Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group. ( Müller-Lissner, SA, 1995) |
| "The efficacy of cisapride as a treatment for chronic constipation in children with severe brain damage was studied in 20 children." | 9.08 | Cisapride in neurologically impaired children with chronic constipation. ( Del Giudice, E; Marino, A; Miele, E; Simeone, D; Staiano, A, 1996) |
| "The efficacy and tolerability of cisapride in chronic dyspepsia was evaluated in a randomized, double-blind, placebo-controlled study." | 9.07 | Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial. ( Chung, JM, 1993) |
| "We assessed upper gastrointestinal anatomy and function with contrast radiology and antroduodenal manometry in 51 children with chronic intestinal pseudo-obstruction (CIP) prior to entering these patients into an open-label outpatient trial of cisapride." | 9.07 | Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. ( Di Lorenzo, C; Flores, AF; Garvey, TQ; Hyman, PE; McAdams, L; Tomomasa, T, 1993) |
| "A double-blind, placebo-controlled trial was performed to determine the therapeutic efficacy of cisapride in patients with refractory functional dyspepsia." | 9.07 | Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. ( De Nutte, N; Gooris, JP; Van Eeghem, P; Van Outryve, M, 1993) |
| "The effect of cisapride (20 mg bid), a new prokinetic drug, on bowel habits and laxative consumption was studied in patients with idiopathic painless constipation and chronic laxative intake." | 9.06 | Treatment of chronic constipation with cisapride and placebo. ( Müller-Lissner, SA, 1987) |
| "Twelve patients with chronic constipation refractory to the vigorous use of emollients, enemas, and/or laxatives were chosen for study of the investigational prokinetic agent, Cisapride." | 9.06 | Cisapride for intractable constipation in children: observations from an open trial. ( Heitlinger, L; Li, BU; McClung, HJ; Murray, RD; Rehm, D, 1990) |
| "In a double-blind, placebo-controlled, crossover trial, we investigated the effects of the prokinetic drug cisapride in patients with cystic fibrosis and chronic recurrent distal intestinal obstruction syndrome (DIOS)." | 9.06 | Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome. ( Corey, M; Durie, PR; Ellis, L; Koletzko, S; Spino, M; Stringer, DA, 1990) |
| "The effects of cisapride, a nondopaminolytic motility-enhancing agent, were studied in 56 patients with chronic functional dyspepsia; all had symptoms suggestive of delayed gastric emptying." | 9.06 | Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. ( Deruyttere, M; Heylen, H; Lepoutre, L; Pennoit, H; Samain, H, 1987) |
| "Cisapride appears to be useful as therapy for chronic constipation that is not associated with underlying organic abnormalities or pregnancy and that is refractory to other treatments, such as increased dietary fiber intake or bulk laxatives." | 8.79 | Cisapride for the treatment of chronic idiopathic constipation. ( Beckwith, JV; Gardner, VY; Heyneman, CA, 1995) |
| "To evaluate the effect of cisapride on the total and segmental colonic transit times (CTT's) and on the clinical symptoms in patients with chronic idiopathic constipation, and to elucidate whether the correction of the CTT parallels the symptomatic improvement." | 7.69 | Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time. ( Bak, YT; Kim, JH; Lee, CH, 1996) |
| " Mild adverse reactions were reported in 6 out of 23 cisapride-treated patients and in 10 out of 20 clebopride-treated patients who completed the study." | 6.67 | Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. ( D'Angelo, V; Manzi, G; Mazzacca, G; Minieri, M; Piai, G; Sabbatini, F, 1991) |
| "Cisapride was well tolerated." | 6.67 | Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. ( Cochran, KM; Penney, SC; Wood, SF, 1993) |
| "Gastro-oesophageal reflux (GOR) has been implicated in such clinical phenomena as aspiration pneumonia, bronchospasm or wheezing, apnea, stridor, and hoarseness." | 5.29 | Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride. ( Olafsdottir, E, 1995) |
| "Treatment with cisapride (4 x 10 mg daily) was undertaken." | 5.27 | Effects of cisapride on constipation due to a neurological lesion. ( de Groot, GH; de Pagter, GF, 1988) |
| "The effects of cisapride (10 mg three times daily) on the stool evacuation characteristics, laxative consumption (symptom diary) and motility pattern (rectoanal manometry) were assessed in patients with chronic idiopathic constipation who fulfilled Rome II criteria." | 5.10 | The efficacy of cisapride vs. placebo and diet in patients with chronic constipation. ( Altabas, K; Bilić, A; Dorosulić, Z; Jurcić, D; Mihanović, M; Restek-Petrović, B; Sunić-Omejc, M; Tolj, N, 2003) |
| "To determine whether cisapride is effective in the treatment of children with constipation." | 5.09 | Cisapride for the treatment of constipation in children: A double-blind study. ( Garcia-Aranda, JA; Nurko, S; Worona, LB; Zlochisty, O, 2000) |
| "Cisapride may have a role in the management of chronic idiopathic constipation in children." | 5.09 | Cisapride in management of chronic pediatric constipation. ( Halabi, IM, 1999) |
| "This study confirmed the efficacy of cisapride in chronic idiopathic constipation." | 5.08 | Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group. ( Müller-Lissner, SA, 1995) |
| "The efficacy of cisapride as a treatment for chronic constipation in children with severe brain damage was studied in 20 children." | 5.08 | Cisapride in neurologically impaired children with chronic constipation. ( Del Giudice, E; Marino, A; Miele, E; Simeone, D; Staiano, A, 1996) |
| "A double-blind, placebo-controlled trial was performed to determine the therapeutic efficacy of cisapride in patients with refractory functional dyspepsia." | 5.07 | Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. ( De Nutte, N; Gooris, JP; Van Eeghem, P; Van Outryve, M, 1993) |
| "The effects on gastric emptying and gastrointestinal symptoms of treatment with cisapride alone and in combination with domperidone were investigated in 25 patients with chronic idiopathic dyspepsia." | 5.07 | Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients. ( Iishi, H; Nakaizumi, A; Okuda, S; Tatsuta, M, 1992) |
| "The efficacy and tolerability of cisapride in chronic dyspepsia was evaluated in a randomized, double-blind, placebo-controlled study." | 5.07 | Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial. ( Chung, JM, 1993) |
| "We assessed upper gastrointestinal anatomy and function with contrast radiology and antroduodenal manometry in 51 children with chronic intestinal pseudo-obstruction (CIP) prior to entering these patients into an open-label outpatient trial of cisapride." | 5.07 | Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction. ( Di Lorenzo, C; Flores, AF; Garvey, TQ; Hyman, PE; McAdams, L; Tomomasa, T, 1993) |
| "We conducted a 12-month trial of cisapride (10 mg three times a day) in 21 patients with gastric stasis due to clinically and manometrically diagnosed gastroparesis (N = 9; seven due to diabetes) or chronic intestinal pseudo-obstruction (N = 12)." | 5.07 | Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. ( Abell, TL; Camilleri, M; DiMagno, EP; Hench, VS; Malagelada, JR; Zinsmeister, AR, 1991) |
| "In a double-blind, placebo-controlled, crossover trial, we investigated the effects of the prokinetic drug cisapride in patients with cystic fibrosis and chronic recurrent distal intestinal obstruction syndrome (DIOS)." | 5.06 | Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome. ( Corey, M; Durie, PR; Ellis, L; Koletzko, S; Spino, M; Stringer, DA, 1990) |
| "Twelve patients with chronic constipation refractory to the vigorous use of emollients, enemas, and/or laxatives were chosen for study of the investigational prokinetic agent, Cisapride." | 5.06 | Cisapride for intractable constipation in children: observations from an open trial. ( Heitlinger, L; Li, BU; McClung, HJ; Murray, RD; Rehm, D, 1990) |
| "The effects of cisapride, a nondopaminolytic motility-enhancing agent, were studied in 56 patients with chronic functional dyspepsia; all had symptoms suggestive of delayed gastric emptying." | 5.06 | Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study. ( Deruyttere, M; Heylen, H; Lepoutre, L; Pennoit, H; Samain, H, 1987) |
| "The effect of cisapride (20 mg bid), a new prokinetic drug, on bowel habits and laxative consumption was studied in patients with idiopathic painless constipation and chronic laxative intake." | 5.06 | Treatment of chronic constipation with cisapride and placebo. ( Müller-Lissner, SA, 1987) |
| "Cisapride appears to be useful as therapy for chronic constipation that is not associated with underlying organic abnormalities or pregnancy and that is refractory to other treatments, such as increased dietary fiber intake or bulk laxatives." | 4.79 | Cisapride for the treatment of chronic idiopathic constipation. ( Beckwith, JV; Gardner, VY; Heyneman, CA, 1995) |
| "To evaluate the effect of cisapride on the total and segmental colonic transit times (CTT's) and on the clinical symptoms in patients with chronic idiopathic constipation, and to elucidate whether the correction of the CTT parallels the symptomatic improvement." | 3.69 | Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time. ( Bak, YT; Kim, JH; Lee, CH, 1996) |
| "Cisapride was well tolerated." | 2.67 | Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients. ( Cochran, KM; Penney, SC; Wood, SF, 1993) |
| " Mild adverse reactions were reported in 6 out of 23 cisapride-treated patients and in 10 out of 20 clebopride-treated patients who completed the study." | 2.67 | Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. ( D'Angelo, V; Manzi, G; Mazzacca, G; Minieri, M; Piai, G; Sabbatini, F, 1991) |
| "Visceral myopathy is one of the causes of chronic intestinal pseudo-obstruction." | 2.52 | Abnormal layering of muscularis propria as a cause of chronic intestinal pseudo-obstruction: A case report and literature review. ( Angkathunyakul, N; Molagool, S; Ruangwattanapaisarn, N; Treepongkaruna, S, 2015) |
| "Dyspepsia affects one in four Australians; of those who present in general practice, the majority will have functional or non-ulcer dyspepsia, with no structural explanation for their symptoms." | 2.39 | Modern management of dyspepsia. ( Talley, NJ, 1996) |
| "GERD was the single cause of cough in 24 patients (43%)." | 1.32 | Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. ( Kallay, MC; Poe, RH, 2003) |
| "Chronic dyspepsia is common in children." | 1.31 | Nutritional implications of chronic dyspepsia in childhood. ( Bartsocas, C; Papadimitriou, A; Papadopoulou, A; Siafakas, C; Vazeou, A, 2002) |
| "Gastro-oesophageal reflux (GOR) has been implicated in such clinical phenomena as aspiration pneumonia, bronchospasm or wheezing, apnea, stridor, and hoarseness." | 1.29 | Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride. ( Olafsdottir, E, 1995) |
| "Baclofen was used as a first treatment in patients without evidence of any gastro-oesophageal disease (n = 17), and was undertaken only after full treatment of such disease (n = 55) had failed to solve the hiccup problem (n = 20)." | 1.29 | Baclofen therapy for chronic hiccup. ( Bizec, JL; Cabane, J; Derenne, JP; Guelaud, C; Similowski, T; Whitelaw, WA, 1995) |
| "Treatment with cisapride (4 x 10 mg daily) was undertaken." | 1.27 | Effects of cisapride on constipation due to a neurological lesion. ( de Groot, GH; de Pagter, GF, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (14.29) | 18.7374 |
| 1990's | 30 (61.22) | 18.2507 |
| 2000's | 10 (20.41) | 29.6817 |
| 2010's | 2 (4.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angkathunyakul, N | 1 |
| Treepongkaruna, S | 1 |
| Molagool, S | 1 |
| Ruangwattanapaisarn, N | 1 |
| Shim, LS | 1 |
| Eslick, GD | 1 |
| Kan, AE | 1 |
| Kalantar, JS | 1 |
| Bove, A | 1 |
| Bellini, M | 1 |
| Battaglia, E | 1 |
| Bocchini, R | 1 |
| Gambaccini, D | 1 |
| Bove, V | 1 |
| Pucciani, F | 1 |
| Altomare, DF | 1 |
| Dodi, G | 1 |
| Sciaudone, G | 1 |
| Falletto, E | 1 |
| Piloni, V | 1 |
| Poe, RH | 1 |
| Kallay, MC | 1 |
| Altabas, K | 1 |
| Bilić, A | 1 |
| Jurcić, D | 1 |
| Dorosulić, Z | 1 |
| Mihanović, M | 1 |
| Sunić-Omejc, M | 1 |
| Restek-Petrović, B | 1 |
| Tolj, N | 1 |
| Silk, DB | 1 |
| Bassotti, G | 1 |
| Sietchiping-Nzepa, F | 1 |
| de Roberto, G | 1 |
| Castellani, D | 1 |
| Morelli, A | 1 |
| Muñoz, MT | 1 |
| Solís Herruzo, JA | 1 |
| Guelaud, C | 1 |
| Similowski, T | 1 |
| Bizec, JL | 1 |
| Cabane, J | 1 |
| Whitelaw, WA | 1 |
| Derenne, JP | 1 |
| Müller-Lissner, SA | 2 |
| Camilleri, M | 3 |
| Balm, RK | 2 |
| Zinsmeister, AR | 3 |
| Rudolph, CD | 1 |
| Glassman, MS | 1 |
| Hyman, PE | 1 |
| Di Lorenzo, C | 1 |
| McAdams, L | 1 |
| Flores, AF | 1 |
| Tomomasa, T | 1 |
| Garvey, TQ | 1 |
| Chung, JM | 1 |
| Van Outryve, M | 1 |
| De Nutte, N | 1 |
| Van Eeghem, P | 1 |
| Gooris, JP | 1 |
| Wood, SF | 1 |
| Penney, SC | 1 |
| Cochran, KM | 1 |
| Olafsdottir, E | 1 |
| Gardner, VY | 1 |
| Beckwith, JV | 1 |
| Heyneman, CA | 1 |
| Talley, NJ | 1 |
| Staiano, A | 1 |
| Del Giudice, E | 1 |
| Simeone, D | 1 |
| Miele, E | 1 |
| Marino, A | 1 |
| Doxey, DL | 2 |
| Milne, EM | 2 |
| Harter, A | 1 |
| Hirano, H | 1 |
| Shimosegawa, T | 1 |
| Meguro, T | 1 |
| Shiga, N | 1 |
| Koizumi, M | 1 |
| Toyota, T | 1 |
| Bak, YT | 1 |
| Kim, JH | 1 |
| Lee, CH | 1 |
| Woodman, MP | 1 |
| Cuddeford, D | 1 |
| Pearson, RA | 1 |
| Corrado, G | 1 |
| D'Eufemia, P | 1 |
| Pacchiarotti, C | 1 |
| Cavaliere, M | 1 |
| Rea, P | 1 |
| Frandina, G | 1 |
| Giardini, O | 1 |
| Cardi, E | 1 |
| Petroianu, G | 2 |
| Hein, G | 2 |
| Petroianu, A | 1 |
| Bergler, W | 2 |
| Rüfer, R | 2 |
| Yanagisawa, M | 1 |
| Kusano, M | 2 |
| Doi, I | 1 |
| Motegi, K | 1 |
| Nakamura, K | 1 |
| Kawamura, O | 1 |
| Mori, M | 1 |
| Sekiguchi, T | 2 |
| Halabi, IM | 1 |
| Torii, A | 1 |
| Fernández-Fernández, FJ | 1 |
| González-González, C | 1 |
| Castro-Alvariño, J | 1 |
| Sesma, P | 1 |
| Nurko, S | 1 |
| Garcia-Aranda, JA | 1 |
| Worona, LB | 1 |
| Zlochisty, O | 1 |
| Stegmeier-Petroianu, A | 1 |
| Loening-Baucke, V | 1 |
| Papadopoulou, A | 1 |
| Vazeou, A | 1 |
| Siafakas, C | 1 |
| Papadimitriou, A | 1 |
| Bartsocas, C | 1 |
| Stanghellini, V | 1 |
| Corinaldesi, R | 1 |
| Ghidini, C | 1 |
| Ricci Maccarini, M | 1 |
| De Giorgio, R | 1 |
| Biasco, G | 1 |
| Brillanti, S | 1 |
| Paparo, GF | 1 |
| Barbara, L | 1 |
| Tatsuta, M | 1 |
| Iishi, H | 1 |
| Nakaizumi, A | 1 |
| Okuda, S | 1 |
| Sabbatini, F | 1 |
| Minieri, M | 1 |
| Manzi, G | 1 |
| Piai, G | 1 |
| D'Angelo, V | 1 |
| Mazzacca, G | 1 |
| Abell, TL | 1 |
| DiMagno, EP | 1 |
| Hench, VS | 1 |
| Malagelada, JR | 1 |
| Nishioka, T | 1 |
| Matsuzaki, T | 1 |
| Sugiyama, M | 1 |
| Horikoshi, T | 1 |
| Toki, M | 1 |
| Ohwada, T | 1 |
| Kobayashi, S | 1 |
| Koletzko, S | 1 |
| Corey, M | 1 |
| Ellis, L | 1 |
| Spino, M | 1 |
| Stringer, DA | 1 |
| Durie, PR | 1 |
| Murray, RD | 1 |
| Li, BU | 1 |
| McClung, HJ | 1 |
| Heitlinger, L | 1 |
| Rehm, D | 1 |
| Jian, R | 1 |
| Ducrot, F | 1 |
| Ruskone, A | 1 |
| Chaussade, S | 1 |
| Rambaud, JC | 1 |
| Modigliani, R | 1 |
| Rain, JD | 1 |
| Bernier, JJ | 1 |
| Ewe, K | 1 |
| Deruyttere, M | 1 |
| Lepoutre, L | 1 |
| Heylen, H | 1 |
| Samain, H | 1 |
| Pennoit, H | 1 |
| Cohen, NP | 1 |
| Booth, IW | 1 |
| Parashar, K | 1 |
| Corkery, JJ | 1 |
| Binnie, NR | 1 |
| Creasey, GH | 1 |
| Edmond, P | 1 |
| Smith, AN | 1 |
| de Groot, GH | 1 |
| de Pagter, GF | 1 |
6 reviews available for cisapride and Chronic Disease
| Article | Year |
|---|---|
Abnormal layering of muscularis propria as a cause of chronic intestinal pseudo-obstruction: A case report and literature review.
Topics: Biomarkers; Biopsy; Brachydactyly; Chronic Disease; Cisapride; Digestive System Abnormalities; Enter | 2015 |
[Chronic intestinal pseudo-obstruction].
Topics: Chronic Disease; Cisapride; Dietary Supplements; Endoscopy; Gastrointestinal Agents; Humans; Intesti | 2007 |
Cisapride for the treatment of chronic idiopathic constipation.
Topics: Chronic Disease; Cisapride; Clinical Trials as Topic; Constipation; Female; Gastrointestinal Agents; | 1995 |
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; C | 1996 |
Controversies in the management of chronic constipation.
Topics: Cathartics; Child; Chronic Disease; Cisapride; Constipation; Dietary Fiber; Feedback; Gastrointestin | 2001 |
[Therapy of obstipation].
Topics: Biofeedback, Psychology; Cathartics; Chronic Disease; Cisapride; Constipation; Humans; Narcotic Anta | 1989 |
20 trials available for cisapride and Chronic Disease
| Article | Year |
|---|---|
The efficacy of cisapride vs. placebo and diet in patients with chronic constipation.
Topics: Adult; Aged; Chronic Disease; Cisapride; Constipation; Diet; Female; Gastrointestinal Agents; Humans | 2003 |
Cisapride in chronic idiopathic constipation: can the colon be re-educated? Bavarian Constipation Study Group.
Topics: Adult; Chronic Disease; Cisapride; Colon; Constipation; Defecation; Double-Blind Method; Humans; Pip | 1995 |
Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder.
Topics: Adult; Autonomic Nervous System; Autonomic Nervous System Diseases; Chronic Disease; Cisapride; Doub | 1994 |
Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction.
Topics: Child, Preschool; Chronic Disease; Cisapride; Enteral Nutrition; Female; Humans; Intestinal Pseudo-O | 1993 |
Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Chronic Disease; Cisapride; Double-Blind Method; Dyspepsia; Female; Gastrointesti | 1993 |
Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cisapride; Domperidone; Double-Blind Method; Dyspepsia; Fe | 1993 |
Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients.
Topics: Abdominal Pain; Adult; Aged; Chronic Disease; Cisapride; Double-Blind Method; Dyspepsia; Family Prac | 1993 |
Cisapride in neurologically impaired children with chronic constipation.
Topics: Brain Damage, Chronic; Child; Child, Preschool; Chronic Disease; Cisapride; Constipation; Defecation | 1996 |
Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility.
Topics: Adult; Aged; Anti-Ulcer Agents; Autonomic Nervous System Diseases; Chronic Disease; Cisapride; Femal | 1996 |
An evaluation of the use of cisapride in horses with chronic grass sickness (equine dysautonomia)
Topics: Animals; Anti-Ulcer Agents; Autonomic Nervous System Diseases; Chronic Disease; Cisapride; Female; G | 1996 |
Cisapride in management of chronic pediatric constipation.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Cisapride; Constipation; Double-Blind Method; | 1999 |
Cisapride for the treatment of constipation in children: A double-blind study.
Topics: Adolescent; Analysis of Variance; Cathartics; Chi-Square Distribution; Child; Child, Preschool; Chro | 2000 |
Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients.
Topics: Chronic Disease; Cisapride; Domperidone; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; | 1992 |
Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Benzamides; Chronic Disease; Cisapride; | 1991 |
Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
Topics: Administration, Oral; Adult; Body Weight; Chronic Disease; Cisapride; Double-Blind Method; Female; G | 1991 |
Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome.
Topics: Adolescent; Adult; Chronic Disease; Cisapride; Cystic Fibrosis; Double-Blind Method; Female; Humans; | 1990 |
Cisapride for intractable constipation in children: observations from an open trial.
Topics: Adolescent; Anal Canal; Child; Child, Preschool; Chronic Disease; Cisapride; Constipation; Encopresi | 1990 |
Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.
Topics: Adult; Chronic Disease; Cisapride; Clinical Trials as Topic; Double-Blind Method; Dyspepsia; Female; | 1989 |
Treatment of chronic constipation with cisapride and placebo.
Topics: Cathartics; Chronic Disease; Cisapride; Clinical Trials as Topic; Constipation; Consumer Behavior; D | 1987 |
Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cisapride; Clinical Trials as Topic; Double-Blind Method; | 1987 |
23 other studies available for cisapride and Chronic Disease
| Article | Year |
|---|---|
A case of chronic intestinal pseudo-obstruction secondary to primary visceral myopathy.
Topics: Adolescent; Biopsy; Chronic Disease; Cisapride; Female; Gastrointestinal Agents; Humans; Indoles; In | 2008 |
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment).
Topics: Chronic Disease; Cisapride; Clinical Trials as Topic; Colectomy; Constipation; Dietary Fiber; Gastro | 2012 |
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Chronic Disease; Cisapride; | 2003 |
Pseudo-pseudo-obstruction: lessons in diagnosis and management.
Topics: Chronic Disease; Cisapride; Diagnosis, Differential; Gastrointestinal Agents; Humans; Intestinal Pse | 2004 |
Pseudo-pseudo-obstruction.
Topics: Abdominal Pain; Chronic Disease; Cisapride; Diagnosis, Differential; Female; Gastrointestinal Agents | 2004 |
Baclofen therapy for chronic hiccup.
Topics: Anti-Ulcer Agents; Baclofen; Chronic Disease; Cisapride; Dose-Response Relationship, Drug; Female; G | 1995 |
Diagnosis of pseudo-obstruction in children.
Topics: Child; Chronic Disease; Cisapride; Electromyography; Gastrointestinal Motility; Gastrointestinal Tra | 1993 |
Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride.
Topics: Anti-Ulcer Agents; Asthma; Child; Child, Preschool; Chronic Disease; Cisapride; Gastroesophageal Ref | 1995 |
Recovery of horses from dysautonomia (grass sickness).
Topics: Animals; Autonomic Nervous System Diseases; Chronic Disease; Cisapride; Female; Follow-Up Studies; G | 1995 |
Effects of ethanol on meal-stimulated secretion of pancreatic polypeptide and cholecystokinin: comparison of healthy volunteers, heavy drinkers, and patients with chronic pancreatitis.
Topics: Adult; Alcoholism; Analysis of Variance; Atropine; Cholecystokinin; Chronic Disease; Cisapride; Etha | 1996 |
Cisapride in chronic idiopathic constipation: clinical response and effect on colonic transit time.
Topics: Adult; Chronic Disease; Cisapride; Colon; Constipation; Female; Gastrointestinal Motility; Humans; M | 1996 |
Irritable oesophagus syndrome as cause of chronic cough.
Topics: Chronic Disease; Cisapride; Cough; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Hydrogen-Io | 1996 |
[ETICS Study: Empirical therapy of idiopathic chronic singultus].
Topics: Acetates; Aged; Aged, 80 and over; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxyl | 1998 |
[Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
Topics: Aged; Chronic Disease; Cisapride; Drug Therapy, Combination; Erythromycin; Female; Gastrointestinal | 1998 |
[Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)].
Topics: Chronic Disease; Cisapride; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Humans | 1999 |
[Cisapride in idiopathic megacolon-megarectum].
Topics: Adolescent; Chronic Disease; Cisapride; Combined Modality Therapy; Diarrhea; Dilatation, Pathologic; | 1999 |
Gabapentin "add-on therapy" for idiopathic chronic hiccup (ICH).
Topics: Acetates; Aged; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxylic Acids; Drug Admi | 2000 |
Nutritional implications of chronic dyspepsia in childhood.
Topics: Body Weight; Child; Chronic Disease; Cisapride; Dyspepsia; Female; Gastric Emptying; Humans; Male; N | 2002 |
Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction.
Topics: Adult; Chronic Disease; Cisapride; Fasting; Gastrointestinal Motility; Humans; Intestinal Pseudo-Obs | 1992 |
Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
Topics: Adult; Aged; Chronic Disease; Cisapride; Esophagitis, Peptic; Esophagus; Famotidine; Female; Humans; | 1991 |
Successful management of idiopathic intestinal pseudo-obstruction with cisapride.
Topics: Administration, Rectal; Child; Chronic Disease; Cisapride; Humans; Injections, Intravenous; Intestin | 1988 |
The action of cisapride on the chronic constipation of paraplegia.
Topics: Administration, Oral; Adult; Anal Canal; Chronic Disease; Cisapride; Constipation; Female; Gastroint | 1988 |
Effects of cisapride on constipation due to a neurological lesion.
Topics: Adult; Chronic Disease; Cisapride; Constipation; Dose-Response Relationship, Drug; Gastrointestinal | 1988 |